EXCRETION PATHWAYS OF AMPHOTERICIN-B

被引:75
作者
CRAVEN, PC
LUDDEN, TM
DRUTZ, DJ
ROGERS, W
HAEGELE, KA
SKRDLANT, HB
机构
[1] VET ADM AUDIE L MURPHY MEM HOSP,DEPT MED,DIV INFECT DIS,SAN ANTONIO,TX
[2] VET ADM AUDIE L MURPHY MEM HOSP,DEPT PHARMACOL,DIV CLIN PHARMACOL,SAN ANTONIO,TX
[3] UNIV TEXAS,HLTH SCI CTR,SAN ANTONIO,TX 78284
关键词
D O I
10.1093/infdis/140.3.329
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of the biliary system in excretion of amphotericin B was explored in a dog model that allowed either external diversion of all bile or complete biliary obstruction. In dogs with biliary diversion, which were given a single dose o£ amphotericin B intravenously, excretion of amphotericin B in the bile lasted for seven to 10 days and accounted for only 3% ± 2% (mean ± sd) of the dose, whereas excretion in the urine was prolonged (23-35 days) and greater (21% ± 5% of the dose); the stool contained no amphotericin B. However, bile salt depletion may have depressed bilary excretion of amphotericin B: In a dog with an intact biliary system, 19% of the dose was excreted in the stool over 11 days. In dogs given amphotericin B daily, serum levels were 19% ± 3% higher during periods of biliary obstruction than during periods of tree bile flow (P < 0.05). Thus, excretion of amphotericin B in the bile (≤ 19% of the dose) and in the urine (21% of the dose) accounted for a minority of total drug clearance. Nevertheless, prolonged excretion of amphotericin B by these routes after a single dose suggests that infrequent doses of amphotericin B may provide effective treatment for certain forms of fungal infection. © 1979 by The University of Chicago.
引用
收藏
页码:329 / 341
页数:13
相关论文
共 29 条
[1]   AMPHOTERICIN-B PHARMACOKINETICS IN HUMANS [J].
ATKINSON, AJ ;
BENNETT, JE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 13 (02) :271-276
[2]   DISCREPANT RESULTS OF AMPHOTERICIN-B ASSAYS ON FRESH VERSUS FROZEN SERUM SAMPLES [J].
BANNATYNE, RM ;
CHEUNG, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1977, 12 (04) :550-550
[3]   A PHARMACOLOGIC GUIDE TO CLINICAL USE OF AMPHOTERICIN B [J].
BINDSCHADLER, DD ;
BENNETT, JE .
JOURNAL OF INFECTIOUS DISEASES, 1969, 120 (04) :427-+
[4]  
BUTLER WT, 1964, J AM VET MED ASSOC, V144, P399
[5]  
CAMERON JOHN L., 1963, JOUR SURG RES, V3, P39, DOI 10.1016/S0022-4804(63)80078-5
[6]  
COLTON T, 1974, STATISTICS MEDICINE
[7]   RUBIDIUM-86 RELEASE - RAPID AND SENSITIVE ASSAY FOR AMPHOTERICIN-B [J].
DRAZIN, RE ;
LEHRER, RI .
JOURNAL OF INFECTIOUS DISEASES, 1976, 134 (03) :238-244
[8]   TREATMENT OF DISSEMINATED MYCOTIC INFECTIONS - A NEW APPROACH TO AMPHOTERICIN B THERAPY [J].
DRUTZ, DJ ;
SPICKARD, A ;
ROGERS, DE ;
KOENIG, MG .
AMERICAN JOURNAL OF MEDICINE, 1968, 45 (03) :405-&
[9]   AMPHOTERICIN-B SERUM CONCENTRATIONS DURING THERAPY [J].
FIELDS, BT ;
BATES, JH ;
ABERNATHY, RS .
APPLIED MICROBIOLOGY, 1970, 19 (06) :955-+
[10]   RENAL EXCRETION OF BILIRUBIN IN DOGS WITH OBSTRUCTIVE JAUNDICE [J].
FULOP, M ;
BRAZEAU, P .
JOURNAL OF CLINICAL INVESTIGATION, 1964, 43 (06) :1192-+